Kudo A (2011) Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci 68:3201–3207
Article PubMed PubMed Central CAS Google Scholar
Norris RA, Damon B, Mironov V, Kasyanov V, Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts JD, Goodwin RL, Davis J, Hoffman S, Wen X, Sugi Y, Kern CB, Mjaatvedt CH, Turner DK, Oka T, Conway SJ, Molkentin JD, Forgacs G, Markwald RR (2007) Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem 101:695–711
Article PubMed PubMed Central CAS Google Scholar
Conway SJ, Izuhara K, Kudo Y, Litvin J, Markwald R, Ouyang G, Arron JR, Holweg CT, Kudo A (2014) The role of periostin in tissue remodeling across health and disease. Cell Mol Life Sci 71:1279–1288
Article PubMed CAS Google Scholar
Sen K, Lindenmeyer MT, Gaspert A, Eichinger F, Neusser MA, Kretzler M, Segerer S, Cohen CD (2011) Periostin is induced in glomerular injury and expressed de novo in interstitial renal fibrosis. Am J Pathol 179:1756–1767
Article PubMed PubMed Central CAS Google Scholar
Turczyn A, Pańczyk-Tomaszewska M (2021) The role of periostin in kidney diseases. Cent Eur J Immunol 46:494–501
Article PubMed PubMed Central CAS Google Scholar
Mael-Ainin M, Abed A, Conway SJ, Dussaule JC, Chatziantoniou C (2014) Inhibition of periostin expression protects against the development of renal inflammation and fibrosis. J Am Soc Nephrol 25:1724–1736
Article PubMed PubMed Central CAS Google Scholar
Mattoo TK, Chesney RW, Greenfield SP, Hoberman A, Keren R, Mathews R, Gravens-Mueller L, Ivanova A, Carpenter MA, Moxey-Mims M, Majd M, Ziessman HA (2016) Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) trial. Clin J Am Soc Nephrol 11:54–61
Article PubMed CAS Google Scholar
Blais AS, Bolduc S, Moore K (2017) Vesicoureteral reflux: from prophylaxis to surgery. Can Urol Assoc J 11:S13–S18
Article PubMed PubMed Central Google Scholar
Hari P, Meena J, Kumar M, Sinha A, Thergaonkar RW, Iyengar A, Khandelwal P, Ekambaram S, Pais P, Sharma J, Kanitkar M, Bagga A (2024) Evidence-based clinical practice guideline for management of urinary tract infection and primary vesicoureteric reflux. Pediatr Nephrol 39:1639–1668
Shaikh N, Craig JC, Rovers MM, Da Dalt L, Gardikis S, Hoberman A, Montini G, Rodrigo C, Taskinen S, Tuerlinckx D, Shope T (2014) Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr 168:893–900
Mathias S, Greenbaum LA, Shubha AM, Raj JAM, Das K, Pais P (2022) Risk factors for renal scarring and clinical morbidity in children with high-grade and low-grade primary vesicoureteral reflux. J Pediatr Urol 18:225.e221-225.e228
Tseng MH, Lin WJ, Lo WT, Wang SR, Chu ML, Wang CC (2007) Does a normal DMSA obviate the performance of voiding cystourethrography in evaluation of young children after their first urinary tract infection? J Pediatr 150:96–99
Duan X, Chen C, Liu X, Wang T, Feng S, Li J, Li G (2023) Interference of periostin attenuates pathological changes, proinflammatory markers and renal fibrosis in diabetic kidney injury. Genes Genomics 45:1389–1397
Article PubMed CAS Google Scholar
Cho A, Jin W, Lee J, Shin N, Lee MS, Li L, Yang SH, Park KS, Yang CW, Kim DK, Oh YK, Lim CS, Lee JP (2023) Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT. Sci Rep 13:17599
Article PubMed PubMed Central CAS Google Scholar
Çetin N, Kavaz Tufan A, Ak I, Akcar N (2021) The role of late dimercaptosuccinic acid (DMSA) scan and renal ultrasonography for vesicoureteral reflux in older children. J Pediatr Res 8:401–407
Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, Herrington WG, Hill G, Inker LA, Kazancıoğlu R, Lamb E, Lin P, Madero M, McIntyre N, Morrow K, Roberts G, Sabanayagam D, Schaeffner E, Shlipak M, Shroff R, Tangri N, Thanachayanont T, Ulasi I, Wong G, Yang C-W, Zhang L, Levin A (2024) KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 105:S117–S314
Lebowitz RL, Olbing H, Parkkulainen KV, Smellie JM, Tamminen-Möbius TE (1985) International system of radiographic grading of vesicoureteric reflux. Pediatr Radiol 15:105–109
Article PubMed CAS Google Scholar
Schuh MP, Nehus E, Ma Q, Haffner C, Bennett M, Krawczeski CD, Devarajan P (2016) Long-term stability of urinary biomarkers of acute kidney injury in children. Am J Kidney Dis 67:56–61
Article PubMed CAS Google Scholar
Kormann R, Kavvadas P, Placier S, Vandermeersch S, Dorison A, Dussaule J-C, Chadjichristos CE, Prakoura N, Chatziantoniou C (2020) Periostin promotes cell proliferation and macrophage polarization to drive repair after AKI. J Am Soc Nephrol 31:85–100
Article PubMed CAS Google Scholar
Mena AH, Garijo MAG, Abejón VDP, Vidigal FFR (2025) Changes in serum periostin levels in uncontrolled asthma in children (DADO phase 2 study). Allergol Immunopathol (Madr) 53:1–7
Shin JH, Jeon JB, Jeon MC, Park S, Kim H (2023) Expression of periostin in aeroallergen-sensitized children with adenotonsillar hypertrophy. Int J Pediatr Otorhinolaryngol 173:111712
Xiong X, Feng X, Ding Y (2024) Periostin induces epithelial-mesenchymal transition via p38-MAPK pathway in human renal tubular cells by high glucose. Immun Inflamm Dis 12:e70077
Article PubMed PubMed Central CAS Google Scholar
Li X, Liu Y, Hocher J-G, Chu C, Reichetzeder C, Kalk P, Szakallova A, Chen X, Krämer BK, Tepel M, Hocher B (2024) Periostin predicts all-cause mortality in male but not female end-stage renal disease patients on hemodialysis. Cardiorenal Med 14:407–415
Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, Jacobsen SJ (2004) Trends in heart failure incidence and survival in a community-based population. JAMA 292:344–350
Article PubMed CAS Google Scholar
Aghamir SMK, Amiri M, Panahi G, Khatami F, Dehghani S, Moosavi MS (2023) Salivary and serum periostin in kidney transplant recipients. PLoS One 18:e0285256
Article PubMed PubMed Central CAS Google Scholar
Morozova O, Morozov D, Pervouchine D, Einav Y, Lakomova D, Zakharova N, Severgina L, Maltseva L, Budnik I (2020) Urinary biomarkers of latent inflammation and fibrosis in children with vesicoureteral reflux. Int Urol Nephrol 52:603–610
Article PubMed CAS Google Scholar
Bowen SE, Watt CL, Murawski IJ, Gupta IR, Abraham SN (2013) Interplay between vesicoureteric reflux and kidney infection in the development of reflux nephropathy in mice. Dis Model Mech 6:934–941
PubMed PubMed Central Google Scholar
Vaidya VS, Ferguson MA, Bonventre JV (2008) Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol 48:463–493
Article PubMed PubMed Central CAS Google Scholar
Ohta N, Yasudo H, Mizutani M, Matsushige T, Fukano R, Kittaka S, Maehara K, Ichihara K, Ohga S, Hasegawa S (2019) Serum soluble ST2 as a marker of renal scar in pediatric upper urinary tract infection. Cytokine 120:258–263
Article PubMed CAS Google Scholar
Naik PB, Jindal B, Kumaravel S, Halanaik D, Rajappa M, Naredi BK, Govindarajan KK (2022) Utility of urinary biomarkers neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 as a marker for diagnosing the presence of renal scar in children with vesicoureteral reflux (VUR): a cross-sectional study. J Indian Assoc Pediatr Surg 27:83–90
Comments (0)